These authors found that NCX2-positive terminals were increased in the AD cohort, while NCX3-positive terminals were reduced, and they demonstrated that the three isoforms co-localized with Aβ in synaptic terminals [149]. Here, SLC8A2 is linked to Alzheimer disease.